SCHEMBL23975950

SCHEMBL23975950

CNC(C)C(=O)Nc1cccc(F)c1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.59
KMT2A Q03164 7/20 0.59
ATM Q13315 1/20 0.59
KDM4E B2RXH2 1/20 0.57
ALDH1A1 P00352 1/20 0.56
MTOR P42345 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
RAB9A P51151 4/20 0.51
TSHR P16473 1/20 0.51
NPC1 O15118 1/20 0.51
HPGD P15428 1/20 0.51
GAA P10253 3/20 0.50
MAPT P10636 2/20 0.50
XIAP P98170 1/20 0.50
BIRC2 Q13490 1/20 0.50
GFER P55789 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23975946 1.00 MEN1 (0.59) MEN1KMT2AATMKDM4EALDH1A1
Hydrochloric Acid SCHEMBL30225304 0.98 MEN1 (0.58) MEN1KMT2AATMKDM4EALDH1A1
SCHEMBL11310154 0.85 MEN1 (0.64) MEN1KMT2AATMKDM4EALDH1A1
SCHEMBL7433315 0.82 MEN1 (0.61) MEN1KMT2AATMKDM4EALDH1A1
SCHEMBL13255714 0.82 HSD17B10 (0.59) MEN1KMT2AALDH1A1SMN1; SMN2RAB9A
SCHEMBL19675877 0.82 ALDH1A1 (0.59) MEN1KMT2AALDH1A1SMN1; SMN2RAB9A
SCHEMBL8297644 0.81 MEN1 (0.53) MEN1KMT2AATMKDM4EMTOR
SCHEMBL2125145 0.81 MEN1 (0.63) MEN1KMT2AATMKDM4EALDH1A1
SCHEMBL13255712 0.81 HPGD (0.59) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL967254 0.80 SMN1; SMN2 (0.63) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed